BillionToOne, Inc. Class A Common Stock
BLLN · NASDAQ · Healthcare / Diagnostics & Research
Close Sep 15, 2026 · end-of-day
Market Stats
Price History
Open in new tabAbout
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
Company Details
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- CEO
- Dr. Oguzhan Atay Ph.D.
- Employees
- 713
- Headquarters
- 1035 O?Brien Drive, Menlo Park, CA, United States, 94025, USA
- Website
- https://www.billiontoone.com
Leadership
- Dr. Oguzhan Atay Ph.D.Co-Founder, Chairman & CEO · b. 1989
- Dr. David Tsao Ph.D.Co-Founder, President, CTO & Director · b. 1990
- Mr. John D. Lister J.D.Chief Administrative Officer · b. 1975
- Mr. Ross Taylor Jr., M.B.A.Chief Financial Officer · b. 1963
- Ms. Jean HaydenVP of Business Operations & Chief of Staff
- Mr. Thomas P. Lynch J.D.Chief Compliance Officer, General Counsel & Secretary · b. 1967
- Ms. Nancy JohnsonSenior Vice President of Sales & Commercial Operations · b. 1964
- Ms. Jaclyn EngVice President of Marketing
- Mr. Vaghar HaghiriSenior Director of People Operations
- Ms. Shan Riku Sakakibara M.B.A.Chief Product Officer · b. 1984
Financials
Income Statement
| Line item | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue | $305.11M | $152.58M | $71.73M |
| Cost of Revenue | $96.65M | $71.67M | $54.42M |
| Gross Profit | $208.46M | $80.92M | $17.31M |
| Operating Income | $16.02M | $-47.15M | $-69.50M |
| EBITDA | $19.76M | $-27.47M | $-72.94M |
| Net Income | $7.45M | $-41.57M | $-82.68M |
| R&D | $49.38M | $36.60M | $22.41M |
| Interest Expense | $95.00K | $2.39M | $3.27M |
Balance Sheet
| Line item | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Assets | $632.65M | $302.06M | $191.68M |
| Total Liabilities | $152.55M | $134.31M | $161.20M |
| Total Equity | $480.11M | $167.75M | $30.47M |
| Cash | $495.98M | $191.48M | $97.27M |
| Total Debt | $108.89M | $109.38M | $146.35M |
| Net Debt | $-387.08M | $-82.10M | $49.08M |
Cash Flow
| Line item | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Cash Flow | $24.59M | $-41.38M | $-53.67M |
| Investing Cash Flow | $-8.92M | $-5.43M | $82.84M |
| Financing Cash Flow | $288.82M | $141.02M | $13.40M |
| Capital Expenditure | $8.88M | $5.40M | $6.17M |
| Free Cash Flow | $15.71M | $-46.78M | $-59.85M |
Earnings
| Report Date | Aug 5, 2026 | May 7, 2026 | Mar 4, 2026 | Dec 9, 2025 |
|---|---|---|---|---|
| EPS Estimate | $0.15 | $-0.01 | $0.17 | $0.16 |
| EPS Actual | $0.15 | $0.34 | $0.15 | $0.91 |
| Surprise | 0.00% | 3489.00% | -11.76% | 468.75% |
| Timing | After-hours | - | After-hours | After-hours |
Key Statistics & Ratios
- Market Cap
- $5.89B
- Enterprise Value
- $4.99B
- Trailing P/E
- 162.21
- Forward P/E
- 69.93
- Price / Sales
- 14.83
- Price / Book
- 10.05
- EPS
- $0.77
- Book Value
- $11.46
- Revenue (TTM)
- $397.41M
- Gross Profit (TTM)
- $283.22M
- EBITDA
- $50.24M
- Profit Margin
- 8.35%
- Operating Margin
- 5.03%
- Return on Equity
- 10.68%
- Return on Assets
- 5.19%
- Shares Outstanding
- 42.64M
- Shares Float
- 28.81M
- Dividend Yield
- 0.00%
- Dividend Rate
- $0
- Payout Ratio
- 0.00%
Ownership Breakdown
- Institutions
- 45.21%
- Insiders
- 37.05%
- Retail / Other
- 17.74%
Top Institutional Holders
- Adams Street Partners LLC1.71M3.63%
- Civilization Ventures Management, LLC1.10M2.33%
- Baillie Gifford & Co Limited.901.42K1.91%
- BAMCO Inc741.49K1.57%
- T. Rowe Price Associates, Inc.737.52K1.56%
- Neuberger Berman Group LLC709.21K1.50%
- Wasatch Advisors LP518.08K1.10%
- Millennium Management LLC425.03K0.90%
- Amvescap Plc.406.51K0.86%
- Emerald Advisers, LLC375.86K0.80%
- Next Century Growth Investors LLC364.47K0.77%
- Oberweis Asset Management Inc299.03K0.63%
- JPMorgan Chase & Co283.14K0.60%
Top Fund Holders
- Vanguard MStar Total Stk Mkt Idx Invest725.81K1.54%
- Vanguard Small Cap Index524.07K1.11%
- Invesco Discovery A487.50K1.03%
- T. Rowe Price Health Sciences321.48K0.68%
- Baron Discovery Institutional286.83K0.61%
- Oberweis Small-Cap Opportunities264.30K0.56%
- Adams Street Private Eq Navigator LLC M246.94K0.52%